LENZ Therapeutics
Price & Volume
Stats
See moreOpen | $3.57 |
Previous Close | $3.50 |
Day Range | $3.51-$3.70 |
52W Range | $2.80-$32.13 |
Market Cap | $95.8M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $12.3M |
Revenue Growth (YoY) | -72.9% |
Gross Profit (12 Mos) | $10.1M |
Diluted EPS | -$4.52 |
News
See moreYahoo Finance • 3 months ago
Lenz drops as BofA downgrades on a slower VIZZ launch
Yahoo Finance • 4 months ago
William Blair updates conviction list: Oracle in, Meta out and more
Yahoo Finance • 4 months ago
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
Yahoo Finance • 6 months ago
Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls
About
CEO | Mr. Evert B. Schimmelpennink |
CFO | Mr. Daniel R. Chevallard CPA |
Address | 201 Lomas Santa Fe Drive, Solana Beach, CA, United States, 92075 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 40 |